Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02808650
Recruitment Status : Completed
First Posted : June 22, 2016
Last Update Posted : April 15, 2021
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2019
Actual Study Completion Date : March 31, 2021